Allspring Global Investments Holdings LLC Decreases Holdings in The Procter & Gamble Company (NYSE:PG)

Allspring Global Investments Holdings LLC decreased its position in The Procter & Gamble Company (NYSE:PG - Free Report) by 3.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 424,918 shares of the company's stock after selling 14,551 shares during the quarter. Allspring Global Investments Holdings LLC's holdings in Procter & Gamble were worth $73,596,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of PG. Acorn Creek Capital LLC lifted its stake in Procter & Gamble by 2.8% in the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company's stock valued at $376,000 after purchasing an additional 59 shares during the last quarter. Alera Investment Advisors LLC lifted its stake in Procter & Gamble by 1.2% in the 1st quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company's stock valued at $812,000 after purchasing an additional 60 shares during the last quarter. Hudson Value Partners LLC lifted its stake in Procter & Gamble by 4.1% in the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company's stock valued at $250,000 after purchasing an additional 60 shares during the last quarter. Traveka Wealth LLC lifted its stake in Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company's stock valued at $616,000 after purchasing an additional 60 shares during the last quarter. Finally, Fiduciary Alliance LLC lifted its stake in Procter & Gamble by 2.8% in the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company's stock valued at $371,000 after purchasing an additional 61 shares during the last quarter. Institutional investors own 65.77% of the company's stock.

Procter & Gamble Trading Down 1.0 %

NYSE:PG opened at $169.56 on Tuesday. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $400.18 billion, a price-to-earnings ratio of 27.71, a PEG ratio of 3.74 and a beta of 0.41. The firm has a fifty day simple moving average of $171.82 and a two-hundred day simple moving average of $167.33. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $177.94.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period last year, the firm earned $1.83 earnings per share. The business's quarterly revenue was down .6% compared to the same quarter last year. Analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date is Friday, October 18th. Procter & Gamble's dividend payout ratio (DPR) is 65.69%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the firm's stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares of the company's stock, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Ma. Fatima Francisco sold 96,000 shares of the firm's stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the transaction, the chief executive officer now directly owns 13,721 shares of the company's stock, valued at $2,332,570. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Balaji Purushothaman sold 8,842 shares of the firm's stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares in the company, valued at $1,902,451.30. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 383,194 shares of company stock valued at $65,140,718. Corporate insiders own 0.17% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on PG. JPMorgan Chase & Co. increased their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an "overweight" rating in a research note on Thursday, September 19th. Jefferies Financial Group cut shares of Procter & Gamble from a "buy" rating to a "hold" rating and decreased their price target for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. TD Cowen began coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They issued a "buy" rating and a $189.00 price target for the company. Morgan Stanley upped their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a research report on Monday. Finally, Barclays cut shares of Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 price target for the company. in a research report on Monday, September 30th. Nine analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, Procter & Gamble has a consensus rating of "Moderate Buy" and a consensus target price of $177.00.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.